Dean Kamen and Sequel Medtech Revolutionize Diabetes Management with Twiist Pump

Dean Kamen, the inventor of the first portable insulin pump, and Sequel Medtech are introducing Twiist, an innovative insulin pump designed for unparalleled precision in insulin delivery. Unlike traditional pumps that rely on gears or motors, Twiist uses advanced technology to monitor and control fluid flow, ensuring accurate insulin administration while detecting blockages and air. The device, cleared for Type 1 diabetes patients aged six and up, is poised to enhance safety and usability in diabetes management. Sequel Medtech is also collaborating with Tidepool Loop, a groundbreaking app that integrates sensors and insulin delivery systems, aiming for seamless and user-friendly experiences, including Apple Watch compatibility.

​

The team envisions a future of fully closed-loop insulin systems, eliminating manual inputs while enhancing safety and reliability. CEO Alan Lotvin emphasizes personalization, allowing users to engage with their devices as they prefer—whether hands-off or deeply involved. With Twiist and strategic partnerships, Kamen and Sequel are charting a new course in diabetes technology, focused on user empowerment and innovation.